139 related articles for article (PubMed ID: 28217018)
1. Skeletal Metastases Presenting as Superscan on Technetium 99m Methylene Diphosphonate Whole Body Bone Scintigraphy in Different Type of Cancers: A 5-Year Retro-prospective Study.
Manohar PR; Rather TA; Khan SH; Malik D
World J Nucl Med; 2017; 16(1):39-44. PubMed ID: 28217018
[TBL] [Abstract][Full Text] [Related]
2. Superscan on Methylene Diphosphonate Skeletal Scintigraphy in Prostatic Adenocarcinoma: A Common Finding but Rare Etiology.
Chatterjee P; Mukherjee A; Mitra D; Nautiyal A; Roy A
Indian J Nucl Med; 2017; 32(4):369-371. PubMed ID: 29142365
[TBL] [Abstract][Full Text] [Related]
3. Technical note: identifying the prostate cancer 'superscan' by quantitative skeletal scintigraphy.
Hawkins T; Halewood MM
Nucl Med Commun; 2008 Jul; 29(7):654-9. PubMed ID: 18528189
[TBL] [Abstract][Full Text] [Related]
4. Metastatic superscan on (99m)Tc-methylene diphosphonate bone scintigraphy in pediatric neuroblastoma.
Arora S; Dhull VS; Mukherjee A; Tulsyan S; Behera A; Tripathi M
Indian J Nucl Med; 2015; 30(3):286-7. PubMed ID: 26170581
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Intraindividual Comparison of
Rathke H; Afshar-Oromieh A; Giesel FL; Kremer C; Flechsig P; Haufe S; Mier W; Holland-Letz T; De Bucourt M; Armor T; Babich JW; Haberkorn U; Kratochwil C
J Nucl Med; 2018 Sep; 59(9):1373-1379. PubMed ID: 29371410
[TBL] [Abstract][Full Text] [Related]
7. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
[TBL] [Abstract][Full Text] [Related]
8. Bone scan can be spared in asymptomatic prostate cancer patients with PSA of <=20 ng/ml and Gleason score of <=6 at the initial stage of diagnosis.
Tanaka N; Fujimoto K; Shinkai T; Nakai Y; Kuwada M; Anai S; Miyake M; Hirayama A; Hasegawa M; Hirao Y
Jpn J Clin Oncol; 2011 Oct; 41(10):1209-13. PubMed ID: 21862505
[TBL] [Abstract][Full Text] [Related]
9. Frequency of superscan on bone scintigraphy: A systematic review.
Kovacsne A; Kozon I; Bentestuen M; Zacho HD
Clin Physiol Funct Imaging; 2023 Sep; 43(5):297-304. PubMed ID: 37070619
[TBL] [Abstract][Full Text] [Related]
10. Metastatic superscan on (99m)Tc-MDP bone scintigraphy in a case of carcinoma colon: Common finding but rare etiology.
Chakraborty PS; Sharma P; Karunanithi S; Bal C; Kumar R
Indian J Nucl Med; 2014 Jul; 29(3):158-9. PubMed ID: 25210281
[TBL] [Abstract][Full Text] [Related]
11. Serum Alkaline Phosphatase in Newly Diagnosed Genito-Urinary Cancers-Do We Need to Review the Guidelines?
Ravish R; Chirag B P; Gaurav A; Santoshi N; Vinod S J; Sharad N LS; V S
Gulf J Oncolog; 2022 Jan; 1(38):24-30. PubMed ID: 35156641
[TBL] [Abstract][Full Text] [Related]
12. Super-superscan on a bone scintigraphy.
Liu Y
Clin Nucl Med; 2011 Mar; 36(3):227-8. PubMed ID: 21285685
[TBL] [Abstract][Full Text] [Related]
13. The role of Tc-99m (V) DMSA scintigraphy in the evaluation of superscan on bone scintigraphy.
Yüksel D; Ilgan S; Arslan N; Uğur O; Oztürk E; Bayhan H
Clin Nucl Med; 2000 Mar; 25(3):193-6. PubMed ID: 10698416
[TBL] [Abstract][Full Text] [Related]
14. Prostatic specific antigen and bone scan in the diagnosis and follow-up of prostate cancer. Can diagnostic significance of PSA be increased?
Bantis A; Grammaticos P
Hell J Nucl Med; 2012; 15(3):241-6. PubMed ID: 23227460
[TBL] [Abstract][Full Text] [Related]
15. Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate.
Bruwer G; Heyns CF; Allen FJ
Eur Urol; 1999; 35(3):223-7. PubMed ID: 10072624
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of serum prostate specific antigen levels and bone scintigraphy in patients with prostate carcinoma].
Bielickaite J; Zadeikaite R; Jurkiene N; Kiudelis J; Kuprionis G
Medicina (Kaunas); 2003; 39(9):867-71. PubMed ID: 14515049
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
[TBL] [Abstract][Full Text] [Related]
18. Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase.
Wymenga LF; Boomsma JH; Groenier K; Piers DA; Mensink HJ
BJU Int; 2001 Aug; 88(3):226-30. PubMed ID: 11488734
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of bone metastases by Tc-99m MDP imaging in patients with stomach cancer.
Choi CW; Lee DS; Chung JK; Lee MC; Kim NK; Choi KW; Koh CS
Clin Nucl Med; 1995 Apr; 20(4):310-4. PubMed ID: 7788986
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer in patients from rural and suburban areas--PSA value, Gleason score and presence of metastases in bone scan.
Szot W; Kostkiewicz M; Zając J; Owoc A; Bojar I
Ann Agric Environ Med; 2014; 21(4):888-92. PubMed ID: 25528940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
